Related Experiment Video
Updated: Feb 4, 2026
08:21
Non-invasive Assessments of Subjective and Objective Recovery Characteristics Following an Exhaustive Jump Protocol
Published on: June 8, 2017
8.1K
Harnessing the Digital Exhaust: Incorporating wellness into the pharma model
Justin M Wright1, Graham B Jones2
1Technical Research and Development, Novartis Pharmaceuticals, 1 Health Plaza, East Hanover, NJ 07936 USA.
Digital Biomarkers
|October 2, 2018
Summary
The pharmaceutical industry can leverage new biomarker-tracking devices by integrating wellness and patient engagement programs. This requires collaboration with tech industries and robust data management for digital biomarkers to enhance healthcare.
Area of Science:
- Healthcare Technology
- Pharmaceutical Industry Innovation
- Biomarker Development
Background:
- Increasing availability of biomarker-tracking devices offers new healthcare opportunities.
- Current healthcare models can be enhanced by integrating patient engagement and wellness programs.
- The pharmaceutical industry is positioned to play a key role in this evolution.
Purpose of the Study:
- To advocate for a new role for the pharmaceutical industry in leveraging biomarker technology.
- To highlight the need for integrating wellness and patient engagement into pharmaceutical business models.
- To explore the potential of digital biomarkers and systems-based approaches.
Main Methods:
- Review of current trends in biomarker tracking and digital health.
- Analysis of the requirements for medical-grade decision-making using biomarkers.
- Discussion of data management, security, and ownership challenges.
- Exploration of systems-based approaches for digital biomarker interpretation.
Main Results:
- Biomarker-tracking devices present significant opportunities for healthcare innovation.
- Coordinated efforts between pharmaceutical and technology industries are crucial for validating biomarkers.
- Large-scale data management and security are critical for longitudinal studies.
- Digital biomarkers offer potential for enhanced patient engagement and remote monitoring.
Conclusions:
- The pharmaceutical industry can reposition itself by embracing biomarker technology and patient-centric models.
- Collaboration and robust data infrastructure are essential for realizing the potential of digital biomarkers.
- Integrating these advancements within the patient-provider ecosystem can lead to significant near-term industry shifts.
Related Concept Videos
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
299
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
299
01:30Social Foundations of Self IV: Self in Digital Communication
204
Since the early 2000s, computer-mediated communication (CMC) has grown rapidly, playing a crucial role in self-development. A key distinction between CMC and real-life interactions is the lack of a physically present partner. This absence makes non-verbal cues such as facial expressions, body language, and paralinguistic signals unavailable in CMC platforms like email, instant messaging, or social media. The lack of these cues can create ambiguity and complicate how feedback is interpreted.The...
204
02:00Molecular Models
43.7K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.7K
02:18The Bohr Model
81.0K
Following the work of Ernest Rutherford and his colleagues in the early twentieth century, the picture of atoms consisting of tiny dense nuclei surrounded by lighter and even tinier electrons continually moving about the nucleus was well established. This picture was called the planetary model since it pictured the atom as a miniature “solar system” with the electrons orbiting the nucleus like planets orbiting the sun. The simplest atom is hydrogen, consisting of a single proton as the...
81.0K
02:16Stereotype Content Model
15.4K
The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
15.4K
01:20Compartment Models: Two-Compartment Model
7.1K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.1K